# Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery

> **NCT00209521** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 16 (actual)

## Conditions studied

- Ischemic Coronary Artery Disease
- Coronary Artery Bypass Surgery

## Interventions

- **DRUG:** fospropofol
- **DRUG:** propofol

## Key facts

- **NCT ID:** NCT00209521
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00209521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00209521, "Comparison of AQUAVAN® Injection to DISOPRIVAN® Injectable Emulsion for Anesthesia During Coronary Artery Surgery". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00209521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*